Gemfibrozil
Overview
Gemfibrozil is antihyperlipidimic agent and reduces high levels of blood cholesterol. Gemfibrozil is the congener of the first generation fibric acid derivative clofibrate. It differs from clofibrate in its aliphatic chain and has two methyl groups rather than a chlorine atom on the phenoxy group.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Back to top
Back to top
Side Effects
Back to top
Dosage
Gemfibrozil's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.9 to 1.2 g | 1 (1.05) | As recommended. | PO | In two divided doses given 30 min before the morning and evening meals |
Paedriatic Dosage (20kg)
|
| | | | Not Recommended in this Age Group |
Neonatal Dosage (3kg)
|
| | | | Not recommended in this age group |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Gemfibrozil
Back to top
Previous Drug Generic - Next Drug Generic